Researchers conducted a study to compare improvement in symptoms of genitourinary syndrome of menopause between women who underwent fractional vaginal laser therapy and women treated with vaginal estrogen alone.
The results suggest that the current recommended levels for breastfeeding duration are linked to an additional benefit of reduced risk for early menopause.
Practicing gynecologists largely fail to screen women for symptoms of depression during perimenopause, according to a study published in Menopause.
A new risk prediction calculator can make health risk predictions for several outcomes simultaneously in postmenopausal women.
Longer use of estrogen hormone therapy was associated with higher cognitive status in late life, study results show.
Use of menopausal hormonal therapy for 5 years around the start of menopause may be associated with increased risk for breast cancer.
Although use of hormone therapy can have some protective effect on muscle mass in postmenopausal women, the benefit is small in the general population.
The FDA’s marketing approval was supported by data from 690 women (aged 42 to 62 years) who were enrolled in the Study of Women’s Health Across the Nation.
The USPSTF has released its final recommendation statement on the use of menopausal hormone therapy for the primary prevention of chronic conditions.
The researchers note that the importance of weight management cannot be overemphasized, as cardiovascular disease is the leading cause of death in postmenopausal women.
